Cybin D/B/A Helus Pharma (HELP)
HELP chart
Everything the smart money is doing in HELP
This is the HELP details page members see in the GTA Terminal. Previews below are blurred samples; start a free trial to see the live data.
Option Flows for HELP
Every unusual options bet in HELP: size, strikes, expirations and which side the money is on.
Start 14-day free trialAlready a member? Open in the Terminal →Insiders & Congress for HELP
3 insider filings on record for HELP. See who bought and sold, how much, and when.
Start 14-day free trialAlready a member? Open in the Terminal →Institutions for HELP
Which hedge funds and institutions are buying and selling HELP.
Start 14-day free trialAlready a member? Open in the Terminal →Short interest for HELP
Short interest data for HELP through 2026-09-30: percent of shares short, days to cover and the squeeze score.
Start 14-day free trialAlready a member? Open in the Terminal →Financials & earnings for HELP
Eight quarters of revenue, margins and EPS for HELP, every earnings beat and miss, and conference-call notes.
Start 14-day free trialAlready a member? Open in the Terminal →GTA AI for HELP
Ask GTA AI for a trade idea on HELP: bias, entry, stop and target, built from all of the data above.
Start 14-day free trialAlready a member? Open in the Terminal →Sample previews with placeholder values. Then $99/month. Cancel anytime.
Technical summary daily
| Moving average | Simple | Exponential | Signal |
|---|---|---|---|
| MA5 | 10.90 | 10.94 | Sell |
| MA10 | 11.26 | 11.29 | Sell |
| MA20 | 12.17 | 11.73 | Sell |
| MA50 | 12.10 | 11.31 | Sell |
| MA100 | 8.97 | 9.87 | Buy |
| MA200 | 7.54 | 8.48 | Buy |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 26.15 | Oversold |
| MACD(12,26) | -0.38 | Sell |
| Stochastic(14) | 15.36 | Oversold |
| ROC(12) | -17.29 | Sell |
Classic pivot points from the last full session. Technical signals are mechanical readings, not recommendations.
Cybin D/B/A Helus Pharma news
Helus Pharma to Host Investor Presentation on October 21, 2026GlobeNewswire · Oct 8, 2026How do you see Cybin D/B/A Helus Pharma today?
Results show once a few readers have voted today.
Historical data daily, last 20 sessions
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | 10.43 | 11.03 | 11.04 | 9.97 | 2.45M | -5.44% |
| Oct 12, 2026 | 11.03 | 11.78 | 12.73 | 10.99 | 2.34M | -6.53% |
| Oct 09, 2026 | 11.80 | 10.75 | 12.09 | 10.45 | 1.66M | +10.07% |
| Oct 08, 2026 | 10.72 | 10.50 | 10.79 | 10.19 | 1.12M | +2.00% |
| Oct 07, 2026 | 10.51 | 10.63 | 10.81 | 10.44 | 832.1K | -2.32% |
| Oct 06, 2026 | 10.76 | 11.35 | 11.38 | 10.51 | 1.48M | -5.78% |
| Oct 05, 2026 | 11.42 | 11.50 | 11.74 | 11.23 | 1.32M | -2.39% |
| Oct 02, 2026 | 11.70 | 12.30 | 12.30 | 11.52 | 1.41M | -1.76% |
| Oct 01, 2026 | 11.91 | 12.32 | 12.48 | 11.63 | 1.33M | -3.09% |
| Sep 30, 2026 | 12.29 | 12.70 | 12.90 | 12.22 | 822.7K | -3.23% |
| Sep 29, 2026 | 12.70 | 12.60 | 12.97 | 12.44 | 967.3K | +0.87% |
| Sep 28, 2026 | 12.59 | 12.50 | 12.78 | 12.09 | 985.9K | -0.16% |
| Sep 25, 2026 | 12.61 | 12.76 | 12.86 | 12.54 | 805.6K | +0.16% |
| Sep 24, 2026 | 12.59 | 12.80 | 12.88 | 12.28 | 1.46M | -3.30% |
| Sep 23, 2026 | 13.02 | 13.60 | 13.61 | 12.81 | 1.85M | -5.03% |
| Sep 22, 2026 | 13.71 | 14.01 | 14.24 | 13.40 | 2.42M | +0.37% |
| Sep 21, 2026 | 13.66 | 12.65 | 14.05 | 12.65 | 2.87M | +10.43% |
| Sep 18, 2026 | 12.37 | 15.15 | 15.15 | 12.10 | 5.67M | -11.77% |
| Sep 17, 2026 | 14.02 | 13.68 | 14.17 | 13.12 | 3.34M | +4.08% |
| Sep 16, 2026 | 13.47 | 13.30 | 13.69 | 13.16 | 927.8K | +2.67% |
Full history, intraday charts and downloads are in the GTA Terminal.
About Cybin D/B/A Helus Pharma
Helus Pharma Inc. is a clinical stage pharmaceutical company committed to helping minds heal by developing proprietary NSAs, synthetic molecules designed to activate serotonin pathways that are believed to promote neuroplasticity. The Company's proprietary NSAs are intended to address the large unmet need for people who suffer from depression, anxiety, and other mental health conditions. Helus Pharma is working to improve the treatment landscape through the introduction of NSAs that aim to provide durable improvements in mental health. Helus Pharma is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of MDD that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and HLP004, also a proprietary NSA in Phase 2 for GAD. Additionally, Helus Pharma has an extensive research portfolio of investigati
People also watch
FAQ
What is the price of Cybin D/B/A Helus Pharma today?
Cybin D/B/A Helus Pharma (HELP) last traded at 10.43, down 5.44% on the day.
What is the 52-week range of HELP?
Over the past 52 weeks HELP has traded between 3.76 and 15.15.
Is HELP a buy or a sell?
Daily technical indicators currently read Sell (2 buy vs 6 sell signals). That is a mechanical reading, not advice.
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.